30 June 2021 in Bulletin "Biomedicine and sociology"
We studied an antitumor effect of a compound of 4-aminochromene derivatives (AX-554) in the tumor system of breast cancer Ca-755. We used C57Bl / 6 mice, which were subcutaneously injected with a suspension of Ca-755 tumor cells into the right axillary region in the amount of 1×106 cells in 199 solution. AX-554 was administered intragastrically through a tube once on the 48 hours after tumor transplantation, in comparison with reference antitumor drugs with proven antitumor activity, which were used as doxorubicin, paclitaxel. The antitumor activity was judged by the survival rate of animals, the size and morphology of the tumor node. It was shown that the 4-aminochromene derivative AX-554 increases the survival rate of animals with breast cancer by 30% compared with the control group and by 10% with the group receiving doxorubicin. with control. In the study of tumor sections stained with hemotoxylin and eosin in animals treated with AX-554, there were single tumor cells in a state of severe dystrophy, the necrosis zone was 90%, which indicates drug pathomorphosis of the 3rd degree. In animals treated with doxorubicin, atypical cells in the center of the tumor node retained their structure, in the periphery - cells in a state of dystrophy, foci of necrosis accounted for 60%. The morphological picture of the tumor in animals treated with paclitaxel was a drug pathomorphosis of the 2nd degree.
28 June 2025 in Bulletin "Biomedicine and sociology"
The study examined selenium nanoparticles (SeNPs) synthesized by laser ablation. In vitro experiments on human colorectal carcinoma HT29 cell culture were used to study the activity of selenium nanoparticles in suppressing tumor cell growth using a laboratory MTT test with calculation of the IC50 value in comparison with liposomal doxorubicin. Acute toxicity of selenium nanoparticles was determined on white outbred laboratory mice with intraperitoneal and intravenous administration with an assessment of lethal doses LD100 and LD50. Antitumor activity of selenium nanoparticles was studied on C57Bl/6 mice, which were transplanted with MC38 colorectal adenocarcinoma subcutaneously into the left hind paw of the mouse at a concentration of 106 cells per mouse. Starting from day 5, mice in the 3 intervention groups were intraperitoneally injected with SeNPs at doses of 10 mg/kg and 1 mg/kg, solubilized in sterile saline. Animals in the control group received the same volume of saline. Injections of SNPs were performed once a day for 14 days. For 20 days after the start of the experimental exposure, the animals were weighed daily and the size of their tumors was measured using an electronic caliper. It was shown that the liquid nanoform of selenium suppresses tumor cell growth in a wide range of concentrations, the average inhibitory concentration IC50 was 5.2 × 10-6 M, which allows us to confirm the presence of antitumor activity of SNPs in colorectal cancer cell culture. When determining the acute toxicity of selenium nanoparticles, the calculated values of LD50 for intraperitoneal administration were 502 [430 ÷ 575] mg/kg; LD100 in mice for intravenous administration was 415 [355 ÷ 480] mg/kg, which corresponds to class 3 – moderately toxic substances according to international regulations. In mice of the experimental group, no significant differences from the control were observed until the 9th day of injections of both doses of selenium nanoparticles, but starting from the 10th day of injections, a decrease in tumor volumes was observed compared to the control, and already on the 12th day, noticeable inhibition of tumor growth was observed. Moreover, this indicator was 2-2.5 times less than in the control, and there were no significant differences between the two experimental groups receiving different doses of selenium nanoparticles. The obtained results allow us to suggest that selenium nanoparticles have their own antitumor effect.
30 December 2021 in Bulletin "Biomedicine and sociology"
The work studied the antitumor activity of a new compound, a pyridine derivative LHT-13-19. To determine the effective inhibitory concentration, a culture of human colon cancer HCT116 was used. Incubation of tumor cells was carried out in the presence of LHT-13-19 in the concentration range from 10-9 to 10-7 M. The survival of tumor cells was determined in MTT test. In vivo experiments were performed on thirty athymic humanized 12-week-old female BALB/c nu/nu mice with xenograft colorectal adenocarcinoma. All animals were divided into 3 groups, 10 mice in each: animals of the control group were injected daily intraperitoneally with 0.5 ml of PBS, animals of the second group were treated with a cyclophosphamide at a dose of 10 mg/kg, mice of the third the groups received LHT-13-19 as experimental therapy at a daily dose of 3.7 mg/kg during 10 days. Animals’ survival and antitumor activity were assessed. Tumor-doubling time, the number of liver superficial metastases and survival time were estimated. Daily incubation of human colon tumor cells with LHT-13-19 is accompanied by the formation of the cytotoxic effect of the compound. On a xenograft model of colon adenocarcinoma in humanized BALB/c nu/nu mice, a 10-day course of 3.7 mg/kg LHT-13-19 leads to the formation of an antitumor effect due to increase in the time of tumor doubling, animal survival and a decrease in the frequency of metastasis
30 September 2025 in “Educational bulletin “Consciousness”
The study involved a newovel compound, a benzoxazinone derivative Rog014. QSAR analysis was performed using the PASSonline software. The ADME methodology was used to predict pharmacokinetic parameters. Screening for antitumor activity of the compound included in the A549 tumor culture (human non-small cell lung adenocarcinoma); non-tumor human fetal lung fibroblasts MRC-5 were used for the primary safety assessment of the compound. As a result of bioinformatics prediction of biological activity of benzoxazine-2-thione compound Rog014, biological targets and types of action were established, which determine the possibility of implementing substances with antitumor activity. According to its physicochemical properties, the limiting substance has moderate lipophilicity, can be absorbed from the gastrointestinal tract, is able to penetrate the blood-brain barrier and, for determining the characteristics, can be considered as a candidate for drugs. When incubating A549 cell culture with benzoxazine-2-thione compound Rog014, IC50 was measured at 4.1 × 10-5 M; while incubation of human fibroblast culture during the study does not lead to an additional cellular side. Compound Rog014 can be considered as a candidate for an antitumor drug.